Literature DB >> 6328055

Herpesvirus infections in the acquired immune deficiency syndrome.

G V Quinnan, H Masur, A H Rook, G Armstrong, W R Frederick, J Epstein, J F Manischewitz, A M Macher, L Jackson, J Ames.   

Abstract

Herpesvirus infections were studied in persons with or at risk for the acquired immune deficiency syndrome (AIDS). The infections diagnosed were as follows: patients with AIDS, cytomegalovirus (CMV) in 34 of 34, Epstein-Barr virus (EBV) in 33 of 34, herpes simplex viruses (HSV) in eight of 34, and varicella zoster virus in four of 34; patients with chronic lymphadenopathy syndrome, CMV in eight of nine and EBV in nine of nine; in healthy homosexual men, CMV in five of 13 and EBV in seven of eight. Cytomegalovirus infections were frequently related to disease and death. Herpesvirus infections are frequent causes of serious diseases in AIDS. The prevalence of EBV and CMV infections in AIDS and the chronic lymphadenopathy syndrome may be the result of an important interaction between these viruses and the cause of AIDS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328055

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  58 in total

1.  Comparison of six commercial DNA extraction kits for recovery of cytomegalovirus DNA from spiked human specimens.

Authors:  G A Fahle; S H Fischer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patients.

Authors:  T L Kuhls; S Viker; N B Parris; A Garakian; J Sullivan-Bolyai; J D Cherry
Journal:  Am J Public Health       Date:  1987-10       Impact factor: 9.308

3.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Cytomegalovirus infection associated with ulcerative colitis in immunocompetent individuals.

Authors:  C Rachima; E Maoz; S Apter; M Thaler; E Grossman; T Rosenthal
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401

5.  An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-92.

Authors:  T G Wreghitt; J Whipp; C Redpath; W Hollingworth
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

Review 6.  Neurologic complications of the acquired immune deficiency syndrome.

Authors:  W R Slade
Journal:  J Natl Med Assoc       Date:  1987-08       Impact factor: 1.798

7.  Cytomegalovirus infection complicating immunosuppressive treatment.

Authors:  P D Griffiths
Journal:  Postgrad Med J       Date:  1988-01       Impact factor: 2.401

8.  Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

Authors:  Z H Yang; H L Lucia; R L Tolman; R J Colonno; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.

Authors:  H Mizuma; S Litwin; S Zolla-Pazner
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

10.  Enhanced delivery of ganciclovir to the brain through the use of redox targeting.

Authors:  M E Brewster; K Raghavan; E Pop; N Bodor
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.